Your browser doesn't support javascript.
loading
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
Oprea-Lager, Daniela-Elena; MacLennan, Steven; Bjartell, Anders; Briganti, Alberto; Burger, Irene A; de Jong, Igle; De Santis, Maria; Eberlein, Uta; Emmett, Louise; Fizazi, Karim; Gillessen, Silke; Herrmann, Ken; Heskamp, Sandra; Iagaru, Andrei; Jereczek-Fossa, Barbara Alicja; Kunikowska, Jolanta; Lam, Marnix; Nanni, Cristina; O'Sullivan, Joe M; Panebianco, Valeria; Sala, Evis; Sathekge, Mike; Sosnowski, Roman; Tilki, Derya; Tombal, Bertrand; Treglia, Giorgio; Tunariu, Nina; Walz, Jochen; Yakar, Derya; Dierckx, Rudi; Sartor, Oliver; Fanti, Stefano.
Afiliación
  • Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, The Netherlands. Electronic address: d.oprea-lager@amsterdamumc.nl.
  • MacLennan S; Academic Urology Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
  • Bjartell A; Department of Translational Medicine, Medical Faculty, Lund University, Lund, Sweden; Department of Urology, Skåne University Hospital, Skåne, Sweden.
  • Briganti A; Department of Urology, Vita e Salute San Raffaele University, Milan, Italy.
  • Burger IA; Nuclear Medicine Department, Kantonspital Baden, Baden, Switzerland.
  • de Jong I; Department of Urology, University Medical Center Groningen, Groningen, The Netherlands.
  • De Santis M; Department of Urology, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Eberlein U; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
  • Emmett L; Theranostics and Nuclear Medicine Department, St Vincent's Hospital Sydney, Sydney, Australia.
  • Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
  • Gillessen S; Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland; Department of Medical Oncology, Università della Svizzera Italiana, Lugano, Switzerland.
  • Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
  • Heskamp S; Department of Medical Imaging-Nuclear Medicine Radboudumc, Nijmegen, The Netherlands.
  • Iagaru A; Division of Nuclear Medicine and Molecular Imaging, Stanford University Medical Center, Stanford, CA, USA.
  • Jereczek-Fossa BA; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Department of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Kunikowska J; Nuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland.
  • Lam M; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Nanni C; Nuclear Medicine Unit, IRCCS Azienda Ospitaliero-Universitaria di Bologna, Bologna, Italy.
  • O'Sullivan JM; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK; Northern Ireland Cancer Centre, Belfast, UK.
  • Panebianco V; Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy.
  • Sala E; Department of Radiology, Università Cattolica del Sacro Cuore and Advanced Radiology Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Sathekge M; Nuclear Medicine Department, University of Pretoria, Pretoria, South Africa; Nuclear Medicine Department, Steve Biko Academic Hospital, Pretoria, South Africa.
  • Sosnowski R; Department of Urooncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Turkey.
  • Tombal B; Department of Surgery, Cliniques Universitaires Saint Luc, Brussels, Belgium.
  • Treglia G; Clinic of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland; Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
  • Tunariu N; Clinical Radiology, Drug Development Unit and Prostate Cancer Targeted Therapy Clinical Trials, Royal Marsden Hospital, London, UK.
  • Walz J; Department of Urology, Institut Paoli-Calmettes Cancer Centre, Marseille, France.
  • Yakar D; Department of Radiology, University Medical Center of Groningen, Groningen, The Netherlands; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Dierckx R; Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, Groningen, The Netherlands.
  • Sartor O; Departments of Medicine and Urology, Tulane University School of Medicine, New Orleans, LA, USA.
  • Fanti S; Nuclear Medicine Division, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S.Orsola, Bologna, Italy.
Eur Urol ; 85(1): 49-60, 2024 01.
Article en En | MEDLINE | ID: mdl-37743194
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Medicina Nuclear Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Medicina Nuclear Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2024 Tipo del documento: Article